Filing Details

Accession Number:
0001225208-24-002196
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-15 17:30:08
Reporting Period:
2024-02-13
Accepted Time:
2024-02-15 17:30:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739940 Cigna Group CI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1710190 P Eric Palmer 900 Cottage Grove Road
Bloomfield CT 06002
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2024-02-13 5,168 $149.14 50,732 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2024-02-13 6,083 $340.00 44,649 No 4 S Direct
Common Stock, $.01 Par Value Acquisiton 2024-02-14 905 $149.14 45,554 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2024-02-15 200 $0.00 45,354 No 4 G Direct
Common Stock, $.01 Par Value Disposition 2024-02-15 312 $0.00 45,042 No 4 G Direct
Common Stock, $.01 Par Value Acquisiton 2024-02-15 312 $0.00 1,437 No 4 G Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 G Direct
No 4 G Direct
No 4 G Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.01 Par Value Employee Stock Option (Right to Buy) Disposition 2024-02-13 5,168 $0.00 5,168 $149.14
Common Stock, $.01 Par Value Employee Stock Option (Right to Buy) Disposition 2024-02-14 905 $0.00 905 $149.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
905 2018-02-28 2027-02-28 No 4 M Direct
0 2018-02-28 2027-02-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $.01 Par Value 245 Indirect By 401(k)
Common Stock, $.01 Par Value 41 Indirect By Spouse's 401(k)
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.